Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 2 1Phase 1/2 1

Status

Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 1

Conditions

Multiple Myeloma 64Burkitt Lymphoma 10Recurrence 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, B-Cell 4Carcinoma, Non-Small-Cell Lung 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms, Plasma Cell 3Lymphoma, Non-Hodgkin 3Smoldering Multiple Myeloma 2Rectal Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lung Neoplasms 2Immunoglobulin Light-chain Amyloidosis 2Down Syndrome 2beta-Thalassemia 1Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thalassemia 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Neoplasms 1Plasmacytoma 1

Interventions

Cyclophosphamide 14fludarabine 8Rituximab 6Specimen Handling 5Magnetic Resonance Spectroscopy 5Vincristine 4Doxorubicin 4Dexamethasone 4zanubrutinib 3Prednisone 3Nivolumab 3Etoposide 3tazemetostat 2tafasitamab 2pirtobrutinib 2pembrolizumab 2glofitamab 2etoposide phosphate 2cemiplimab 2acalabrutinib 2Leukapheresis 2Immunotherapy, Adoptive 2Immunoglobulin G 2Gemcitabine 2Disulfides 2Cisplatin 2Cell- and Tissue-Based Therapy 2Biopsy 2venetoclax 1varlilumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Lymphoma, B-Cell × Dexamethasone × 30 days × Clear all
NCT03114865 2026-06-03

A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Active not recruiting
44 enrolled
LymphoidOther hematologic neoplasm

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07588698 2026-05-15

Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma

University of California, San Francisco

Phase 2 Not yet recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04161248 2026-05-12

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Canadian Cancer Trials Group

Phase EARLY_PHASE1 Active not recruiting
40 enrolled
Lymphoid

Lymphoma, B-Cell

NCT06230224 2026-05-11

OLYMPIA-4

Regeneron Pharmaceuticals

Phase 3 Active not recruiting
216 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡